Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma

Published:2016-02-24 Issue:13 Volume:7 Page:16433-16444
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Xiaoying¹²,Xiao Xue¹,Huang Tingting¹,Du Chunping¹,Wang Shumin¹,Mo Yingxi¹³,Ma Ning⁴,Murata Mariko³,Li Bo¹,Wen Wensheng¹,Huang Guangwu¹,Zeng Xianjie⁵,Zhang Zhe¹

Affiliation:

1. Department of Otolaryngology-Head & Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China

2. Medical Research Center, Guangxi Medical University, Nanning, China

3. Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Mie, Japan

4. Faculty of Nursing Science, Suzuka University of Medical Science, Suzuka, Japan

5. Department of Head and Neck Surgery, Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Serum Follistatin-Like Protein 1 Levels and Disease Activity in Behçet’s Disease;Aktuelle Rheumatologie;2023-12-19

2. Pathogenesis and therapeutic implications of EBV-associated epithelial cancers;Frontiers in Oncology;2023-10-02

3. Role of follistatin-like protein 1 in liver diseases;Experimental Biology and Medicine;2022-12-19

4. Follistatin-Like Proteins: Structure, Functions and Biomedical Importance;Biomedicines;2021-08-12

5. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway;Cancer Chemotherapy and Pharmacology;2021-01-03